During this segment, the panelists discuss the various roles that specialty pharmacies perform to assist patients with systemic lupus erythematosus (SLE) and hemophilia.
Hugh Fatodu, RPh, MBA, explains that in SLE, where the disease presents in many different ways and affects many different organ systems, specialty pharmacies coordinate the massive flow of information between different healthcare specialties.
Patrick F. Fogarty, MD, recognizes programs organized by hemophilia treatment centers that provide cost saving incentives and enhance patient care.
However, Maria Lopes, MD, MS, shares her concern about the expensive costs of investigational drugs and the lack of coverage to patients who may require necessary treatment with these products. Dr Lopes suggests that in order to ensure that all treatment options are considered appropriately, there is a need for dynamic conversation between key opinion leaders to discuss missed opportunities within the medical field.
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen